CTSO - Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript
2024-05-09 23:01:03 ET
Cytosorbents Corporation (CTSO)
Q1 2024 Earnings Conference Call
May 9, 2024 16:30 ET
Company Participants
Eric Ribner - Investor Relations
Phil Chan - Chief Executive Officer
Vincent Capponi - President and Chief Operating Officer
Kathleen Bloch - Chief Financial Officer
Makis Deliargyris - Chief Medical Officer
Christian Steiner - Executive Vice President, Sales and Marketing
Christopher Cramer - Senior Vice President, Business Development
Conference Call Participants
Yuan Zhi - B. Riley Securities
Sean Lee - H.C. Wainwright
Tom Kerr - Zacks Investment Research
Presentation
Operator
Good afternoon and welcome to CytoSorbents’ First Quarter 2024 Financial and Operating Results Conference Call. [Operator Instructions] Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company’s request. At this time, I’d like to turn the call over to our moderator, Eric Ribner. Please go ahead, Mr. Ribner.
Eric Ribner
Thank you and good afternoon. Welcome to CytoSorbents’ first quarter 2024 financial and operating results conference call. Joining me from the company are Dr. Phil Chan, Chief Executive Officer; Vincent Capponi, President and Chief Operating Officer; Kathleen Bloch, Chief Financial Officer; Dr. Makis Deliargyris, Chief Medical Officer; Dr. Christian Steiner, Executive Vice President of Sales and Marketing; Christopher Cramer, Senior Vice President of Business Development.
Before I turn the call over to Dr. Chan, I’d like to remind listeners that during the call, management’s prepared remarks may contain forward-looking statements, which are subject to risks and uncertainties. Management may make additional forward-looking statements in response to your questions today. Therefore, the company claims protection under Safe Harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Actual results may differ from the results discussed today and therefore we refer you to more detailed discussion of these risks and uncertainties in the company’s filings with the SEC. Any projections as to the company’s future performance represented by management include estimates today as of May 9, 2024 and we assume no obligation to update these projections in the future as market conditions change....
Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript